自動化細胞培養市場規模、佔有率和成長分析：按產品類型、細胞類型、應用、工作流程、最終用戶、自動化程度和地區分類－2026-2033年產業預測

2024 年全球自動化細胞培養市場價值為 153 億美元，預計到 2033 年將成長至 338.1 億美元，而 2025 年為 167.1 億美元，預測期（2026-2033 年）的複合年成長率為 9.21%。

全球自動化細胞培養市場在生物製造領域的地位日益鞏固，這主要得益於藥物研發和再生醫學領域對高通量、可重複性檢測方法的日益成長的需求。傳統的人工操作流程在規模化方面面臨挑戰，而機器人液體處理系統的引入則有效緩解了這些問題。整合式培養箱、成像系統和人工智慧驅動的實驗方案的最新進展簡化了實驗室工作流程，實現了在保持無菌條件下同時處理數千個培養物。這項進步不僅縮短了研發週期、降低了人事費用，也有助於提高治療數據的可靠性。該市場的未來成長與個人化醫療和數位健康密切相關，這將加速封閉式、擴充性培養系統在個人化治療中的應用，並透過即時監控和雲端分析提升效率。

全球自動化細胞培養市場促進因素

全球自動化細胞培養市場的發展動力源自於自動化技術的進步，這些技術能夠更好地控制環境因素，並最大限度地降低變異性和污染風險。這些技術可以處理常規任務，使負責人能夠專注於更複雜的工作，最終提高細胞衍生產品的可重複性，並加速研發進程。營運效率和產品品質的提升增強了相關人員的信心，促使自動化細胞培養系統在研發和生產環境中得到更廣泛的應用和整合。此外，這些創新也促進了學術機構和產業界之間的合作，在遵守監管標準的前提下，加速了治療方法的進步。

全球自動化細胞培養市場的限制因素

全球自動化細胞培養市場面臨嚴峻挑戰，主要原因是自動化細胞培養系統初始成本高昂，包括硬體、軟體以及必要的設施維修費用。這種經濟負擔會嚴重影響科學研究機構和小規模生技公司的預算，可能導致他們在採購決策上猶豫不決。因此，一些機構可能會選擇繼續採用短期成本較低的傳統手工技術。這種資本密集型壁壘阻礙了自動化解決方案的快速市場准入，尤其是在資金有限的地區，最終減緩了自動化解決方案在行業的廣泛應用，並限制了早期採用者的競爭優勢。

自動化細胞培養市場的全球趨勢

全球自動化細胞培養市場正呈現出人工智慧驅動的流程最佳化顯著融合的趨勢。先進的人工智慧演算法被無縫整合到自動化細胞培養平台中，徹底革新了實驗室的工作流程。這些系統利用機器學習分析即時感測器數據，能夠預測最佳補料方案並自動調節環境參數，無需人工干預。這種自動化最大限度地減少了批次間的差異，縮短了實驗週期，並使負責人能夠專注於更具策略性的任務。隨著人工智慧技術日趨直覺易用，生物製藥公司和學術研究機構正擴大利用這些智慧解決方案，透過強大的數據驅動洞察來提高實驗的可重複性並加速藥物研發進程。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 宏觀經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球自動化細胞培養市場規模：依產品類型分類

• 自動化細胞培養系統
  • 生物反應器系統
  • 自動化培養系統
  • 細胞增殖系統
  • 自動化培養基交換系統
• 耗材和配件
  • 培養基
  • 試劑
  • 免洗耗材
• 軟體
  • 監控軟體
  • 製程管制軟體

全球自動化細胞培養市場規模：依細胞類型分類

• 哺乳動物細胞
• 幹細胞
• 微生物細胞
• 昆蟲細胞
• 其他

全球自動化細胞培養市場規模：依應用分類

• 藥物發現與開發
• 再生醫學
• 疫苗生產
• 細胞和基因治療
• 毒性測試
• 學術研究
• 其他

全球自動化細胞培養市場規模：依工作流程分類

• 細胞分離
• 細胞接種
• 細胞增殖
• 細胞監測
• 收穫和加工

全球自動化細胞培養市場規模：依最終用戶分類

• 生物製藥公司
• 受託研究機構
• 合約研發生產組織（CDMO）
• 學術研究機構
• 醫院/診斷檢查室

全球自動化細胞培養市場規模：依自動化程度分類

• 全自動
• 半自動

全球自動化細胞培養市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Thermo Fisher Scientific Inc.
• Sartorius AG
• Danaher Corporation
• Merck KGaA
• Eppendorf SE
• Corning Incorporated
• Hamilton Company
• Getinge AB
• Lonza Group AG
• Agilent Technologies Inc.
• FUJIFILM Holdings Corporation
• BD（Becton, Dickinson and Company）
• Bio-Rad Laboratories Inc.
• Tecan Group Ltd.
• PerkinElmer Inc.
• Automata Technologies Ltd.
• Cell Culture Company LLC
• Kuhner AG
• PBS Biotech Inc.
• Esco Lifesciences Group

結論與建議

Global Automated Cell Culture Market size was valued at USD 15.3 Billion in 2024 and is poised to grow from USD 16.71 Billion in 2025 to USD 33.81 Billion by 2033, growing at a CAGR of 9.21% during the forecast period (2026-2033).

The global automated cell culture market has solidified its role in biomanufacturing, largely due to rising demands for high-throughput and reproducible assays in drug discovery and regenerative medicine. Traditional manual processes posed scalability challenges, but the introduction of robotic liquid-handling systems has alleviated these issues. Recent advancements in integrated incubators, imaging systems, and AI-driven protocols have streamlined laboratory workflows, allowing simultaneous processing of thousands of cultures while ensuring sterility. This progress not only shortens development timelines and reduces labor costs but also reinforces the reliability of therapeutic data. The future growth of this market is linked to personalized medicine and digital health, promoting the use of closed, scalable culture systems for patient-specific therapies and enhancing efficiency through real-time monitoring and cloud-based analytics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Automated Cell Culture market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Automated Cell Culture Market Segments Analysis

Global automated cell culture market is segmented by by product type, by cell type, by application, by workflow, by end user, by automation level and region. Based on by product type, the market is segmented into Automated Cell Culture Systems, Consumables & Accessories and Software. Based on by cell type, the market is segmented into Mammalian Cells, Stem Cells, Microbial Cells, Insect Cells and Others. Based on by application, the market is segmented into Drug Discovery & Development, Regenerative Medicine, Vaccine Production, Cell & Gene Therapy, Toxicity Testing, Academic Research and Others. Based on by workflow, the market is segmented into Cell Isolation, Cell Seeding, Cell Expansion, Cell Monitoring and Harvesting & Processing. Based on by end user, the market is segmented into Biopharmaceutical Companies, Contract Research Organizations, Contract Development & Manufacturing Organizations, Academic & Research Institutes and Hospitals & Diagnostic Laboratories. Based on by automation level, the market is segmented into Fully Automated and Semi-automated. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Automated Cell Culture Market

The Global Automated Cell Culture market is propelled by the advancements in automation technologies that provide enhanced control over environmental factors, minimizing variability and contamination risks. By taking over routine tasks, these technologies allow skilled personnel to focus on more complex activities, ultimately improving the reproducibility of cell-based products and expediting development processes. This heightened operational efficiency and product quality instill greater confidence in stakeholders, leading to wider adoption and integration of automated cell culture systems in both research and manufacturing environments. Furthermore, these innovations foster collaboration between academic institutions and industry, promoting faster therapeutic advancements while adhering to regulatory standards.

Restraints in the Global Automated Cell Culture Market

The Global Automated Cell Culture market faces significant challenges due to high initial costs associated with automated cell culture equipment, including expenses for hardware, software, and necessary facility alterations. This financial burden can significantly impact the budgets of research institutions and smaller biotech companies, leading to hesitancy in purchasing decisions. As a result, organizations may opt to stick with traditional manual techniques that entail lower short-term expenses. Such capital-intensive barriers hinder swift market entry, particularly in areas with constrained funding, ultimately slowing the widespread acceptance of automation solutions in the industry and restricting the competitive edge for early adopters.

Market Trends of the Global Automated Cell Culture Market

The Global Automated Cell Culture market is witnessing a significant trend towards the integration of AI-driven process optimization. Advanced artificial intelligence algorithms are being seamlessly integrated into automated cell culture platforms, revolutionizing laboratory workflows. These systems utilize machine learning to analyze real-time sensor data, facilitating the prediction of optimal feeding schedules and automatic adjustments of environmental parameters, all without human oversight. This automation not only minimizes batch variability and accelerates experimental timelines but also allows skilled personnel to focus on more strategic tasks. As AI technology becomes more intuitive and accessible, biopharma and academic laboratories are increasingly leveraging these intelligent solutions to enhance reproducibility and expedite discovery processes through robust, data-driven insights.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Automated Cell Culture Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Automated Cell Culture Systems
  • Bioreactor Systems
  • Automated Incubation Systems
  • Cell Expansion Systems
  • Automated Media Exchange Systems
• Consumables & Accessories
  • Culture Media
  • Reagents
  • Single-use Consumables
• Software
  • Monitoring Software
  • Process Control Software

Global Automated Cell Culture Market Size by Cell Type & CAGR (2026-2033)

• Market Overview
• Mammalian Cells
• Stem Cells
• Microbial Cells
• Insect Cells
• Others

Global Automated Cell Culture Market Size by Application & CAGR (2026-2033)

• Market Overview
• Drug Discovery & Development
• Regenerative Medicine
• Vaccine Production
• Cell & Gene Therapy
• Toxicity Testing
• Academic Research
• Others

Global Automated Cell Culture Market Size by Workflow & CAGR (2026-2033)

• Market Overview
• Cell Isolation
• Cell Seeding
• Cell Expansion
• Cell Monitoring
• Harvesting & Processing

Global Automated Cell Culture Market Size by End User & CAGR (2026-2033)

• Market Overview
• Biopharmaceutical Companies
• Contract Research Organizations
• Contract Development & Manufacturing Organizations
• Academic & Research Institutes
• Hospitals & Diagnostic Laboratories

Global Automated Cell Culture Market Size by Automation Level & CAGR (2026-2033)

• Market Overview
• Fully Automated
• Semi-automated

Global Automated Cell Culture Market Size & CAGR (2026-2033)

• North America (By Product Type, By Cell Type, By Application, By Workflow, By End User, By Automation Level)
  • US
  • Canada
• Europe (By Product Type, By Cell Type, By Application, By Workflow, By End User, By Automation Level)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (By Product Type, By Cell Type, By Application, By Workflow, By End User, By Automation Level)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (By Product Type, By Cell Type, By Application, By Workflow, By End User, By Automation Level)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (By Product Type, By Cell Type, By Application, By Workflow, By End User, By Automation Level)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Group Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Automata Technologies Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Culture Company LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kuhner AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PBS Biotech Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esco Lifesciences Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations